Conjunctival autograft versus topical mitomycin C in treatment of pterygium

Eye
P S Mahar

Abstract

A prospective study was carried out to assess the recurrence rate of pterygium with conjunctival autograft versus the use of topical mitomycin C. In 27 eyes undergoing pterygium excision with conjunctival autograft, the recurrence rate was found to be 25.9% after 1 year mean follow-up. In the second group of 32 eyes, pterygium was removed using the bare sclera method. All these patients received post-operatively 0.2 mg/ml (0.02%) topical mitomycin C twice a day for 5 days. At 1 year mean follow-up, the recurrence rate in this group was 9.4%. Although the difference was not statistically significant, the number of recurrences was lower in the mitomycin-C-treated group than in patients undergoing conjunctival autograft.

References

Nov 1, 1992·Ophthalmology·R S RubinfeldM G Speaker
Jul 1, 1992·Ophthalmology·F D MackenzieA Green
Dec 15, 1988·American Journal of Ophthalmology·S HayasakaT Setogawa
Nov 15, 1988·American Journal of Ophthalmology·S HayasakaK Mizuno
Jun 1, 1988·Ophthalmology·G SinghC S Foster
Nov 1, 1985·Ophthalmology·K R KenyonM E Hettinger
Apr 1, 1994·Ophthalmology·J Frucht-Pery, M Ilsar
Jul 1, 1993·The British Journal of Ophthalmology·P S Mahar, G E Nwokora

❮ Previous
Next ❯

Citations

Apr 11, 2003·Survey of Ophthalmology·Lawrence W Hirst
Apr 12, 2003·Ophthalmology·Padmanabha Pillai SyamChristopher S C Liu
May 17, 2003·Ophthalmology·Eric D DonnenfeldSeth Biser
Oct 14, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Sameh S MandourHala M Mohamed
Jul 14, 2006·The British Journal of Ophthalmology·P LuanratanakornR S Chuck
Jun 5, 2013·International Ophthalmology·Sekelj SandraAric Ivana
Aug 3, 2010·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·A M AliJ-P Gérard
Apr 6, 2005·American Journal of Ophthalmology·Leonard P K AngRoger W Beuerman
Mar 21, 2006·American Journal of Ophthalmology·Joseph Frucht-PeryAbraham Solomon
Dec 5, 2014·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Shaaban A M Elwan
Jun 9, 2006·European Journal of Ophthalmology·A Kilic, B Gurler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.